According to BlockBeats, on June 5, the board of directors of Silo Pharma, a publicly listed pharmaceutical company in the US, approved the purchase of Bitcoin worth no more than $1 million as a reserve asset. Silo Pharma's CEO Eric Weisblum stated that incorporating Bitcoin into the company's reserves is a strategic decision to diversify assets through digital value storage and serve as a safeguard against inflation. Silo Pharma expects this move to optimize long-term shareholder value.
Silo Pharma's board approves the purchase of up to $1 million in Bitcoin as a reserve asset
--・
AI Summary
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Relevant Creator
@Binance_News